Middle East Synthetic Biology Market To Reach $705.2 Million By 2033

Middle East Synthetic Biology Market Growth & Trends

The Middle East synthetic biology market size is projected to reach USD 705.2 million by 2033, growing at a CAGR of 13.47% during the forecast period, according to a new report by Grand View Research, Inc. The Middle East synthetic biology market is booming as the regional demand for biotechnological solutions, gene editing, and synthetic biology applications continues to grow. Academic researchers, pharmaceutical companies, and contract research organizations (CROs) utilize advanced enzyme technologies, cloning kits, genome editing tools, and bioinformatics platforms to develop synthetic biology workflows better, improve reproducibility in experiments, and satisfy regulatory requirements. Important partnerships with outstanding biotechnology companies, academic research centers, and clinical laboratories are paving the way for the development and use of synthetic biology. High-quality reagents, automated platforms, and integrated workflow systems enable scalable, reproducible, and cost-effective opportunities in healthcare, agriculture, and industrial biotechnology.

Increased reproducibility, decreased errors, and overall process efficiencies of automated systems, along with real-time monitoring and data-based optimization, improve the quality of experimental outputs and productivity. The market is bolstered by expanding biotechnology infrastructure, increasing government and private initiatives, regulatory support, and technology advancements enabling new biotech solutions. These factors together create an environment where synthetic biology solutions are central to achieving scientific breakthroughs and efficient production processes for therapeutics, bio-based products, and industrial applications in the Middle East.

 Request a free sample copy or view report summary: Middle East Synthetic Biology Market Report

Middle East Synthetic Biology Market Report Highlights

• By product, enzymes dominated the Middle East synthetic biology market in 2024, capturing a significant share of 36.92%. Advances in enzyme engineering, high-throughput production, and improved specificity led to higher efficiencies in cloning, genome editing, and biocatalysis workflows.

• By technology, PCR technology led the Middle East synthetic biology market in 2024, accounting for the largest share of 30.01%. The advancement into next-generation diagnostics, gene editing, and research in molecular biology continue to solidify the technological dominance in the marketplace.

• By application, healthcare dominated the Middle East synthetic biology market in 2024, capturing the largest share. Growth in applications such as regenerative medicine, vaccine development, and targeted therapies maintains healthcare as the leading segment.

• By end use, biotechnology and pharmaceutical companies held the largest share of the Middle East synthetic biology market in 2024, accounting for 54.90%. By working strategically with research institutions, start-ups, and technology providers, companies enable innovation, accelerate product development, and promote synthetic biology solutions across therapeutic, diagnostic, and industrial applications.

Middle East Synthetic Biology Market Segmentation

For this report, Grand View Research has segmented the Middle East synthetic biology market on the basis of product, technology, application, end use, and country:

Middle East Synthetic Biology Product Outlook (Revenue, USD Million, 2021 - 2033)

• Oligonucleotide/Oligo Pools and Synthetic DNA

• Enzymes

• Cloning Technologies Kits

• Xeno-Nucleic Acids

• Chassis Organism

Middle East Synthetic Biology Technology Outlook (Revenue, USD Million, 2021 - 2033)

• NGS Technology

• PCR Technology

• Genome Editing Technology

• Bioprocessing Technology

• Other Technologies

Middle East Synthetic Biology Application Outlook (Revenue, USD Million, 2021 - 2033)

• Healthcare

  • Clinical

    • Bio/Pharmaceuticals

    • Diagnostics

  • Non-Clinical

• Non-healthcare

  • Biotech Crops

  • Specialty Chemicals

  • Bio-fuels

  • Others

Middle East Synthetic Biology End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Biotechnology and Pharmaceutical companies

• Academic and Research Institutes

• Others

Middle East Synthetic Biology Country Outlook (Revenue, USD Million, 2021 - 2033)

• Middle East

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman

  • Rest of Middle East

List of Key Players in the Middle East Synthetic Biology Market

• Bota Biosciences Inc.

• Codexis, Inc.

• Creative Biogene.

• Creative Enzymes.

• Enbiotix, Inc.

• Illumina, Inc.

• Merck Kgaa (Sigma-Aldrich Co. LLC)

• New England Biolabs

• Eurofins Scientific

• Novozymes

• Pareto Bio, Inc.

• Scarab Genomics, LLC

• Synthego

• Synthetic Genomics Inc.

• Thermo Fisher Scientific, Inc.